Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Therapy-Related Diarrhea”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Early research (Phase 1)Looking for participantsNCT06801067
What this trial is testing

SER-155 to Treat Diarrhea in People on Immunotherapy

Who this might be right for
DiarrheaEnterocolitis
Memorial Sloan Kettering Cancer Center 15
Not applicableStudy completedNCT00197873
What this trial is testing

Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea

Who this might be right for
Colorectal Cancer
University of Helsinki 84
Large-scale testing (Phase 3)Study completedNCT00774930
What this trial is testing

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Ipsen 115
Testing effectiveness (Phase 2)Study completedNCT05361668
What this trial is testing

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06807593
What this trial is testing

Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

Who this might be right for
Cancer
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)WithdrawnNCT02763761
What this trial is testing

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Who this might be right for
Renal Cell CarcinomaMelanomaLung Cancer
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT00003057
What this trial is testing

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerDiarrhea
Eastern Cooperative Oncology Group 500
Large-scale testing (Phase 3)Study completedNCT04538625
What this trial is testing

Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy

Who this might be right for
Cancer Therapy-Related DiarrheaChemotherapy-related DiarrheaAdult Solid Tumor+3 more
Napo Pharmaceuticals, Inc. 287
Not applicableNot Yet RecruitingNCT06924645
What this trial is testing

Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study

Who this might be right for
Treatment-related Gastrointestinal Toxicity (Including Diarrhea, Constipation, Nausea, and Vomiting)Extrapulmonary Neuroendocrine Neoplasms
Second Affiliated Hospital, School of Medicine, Zhejiang University 40
Testing effectiveness (Phase 2)WithdrawnNCT01644097
What this trial is testing

Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy

Who this might be right for
DiarrheaUnspecified Adult Solid Tumor, Protocol Specific
Stanford University
Not applicableUnknownNCT05773391
What this trial is testing

Mechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure)

Who this might be right for
Breast Cancer
Sun Yat-sen University 100
Testing effectiveness (Phase 2)WithdrawnNCT04713202
What this trial is testing

Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl

Who this might be right for
Neuroendocrine TumorsCarcinoid SyndromeDiarrhea
Chandrikha Chandrasekhara